Korean Circulation Journal

  • 제42권7호
  • /
  • Pages.441-446
  • /
  • 2012
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Fractional Flow Reserve: The Past, Present and Future

  • Kim, Jeong-Eun (Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital) ;
  • Koo, Bon-Kwon (Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital)
  • 발행 : 2012.07.31
⟨ 이전 논문 다음 논문 ⟩

초록

Revascularization of coronary artery stenosis should be based on the objective evidence of ischemia. It is common practice for physicians to make decisions on revascularization in the cardiac catheterization laboratory based on the results of angiography, despite the fact that angiographic information does not correlate well with the functional significance of a coronary lesion. Fractional flow reserve (FFR) is a physiologic parameter which can be measured easily during the invasive procedure and can assess the functional significance of coronary stenosis. FFR-guided revascularization strategy is reported to be more effective than angiography-guided strategy in patients with coronary artery disease. Moreover, novel technologies based on FFR have been developed and will soon be incorporated into clinical practice.

키워드

참고문헌

  1. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-85. https://doi.org/10.1016/j.nuclcard.2003.12.004
  2. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy. Circulation 2008;117:1283-91. https://doi.org/10.1161/CIRCULATIONAHA.107.743963
  3. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24. https://doi.org/10.1056/NEJMoa0807611
  4. Pijls NH, van Schaardenburgh P, Manoharan G, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007;49:2105-11. https://doi.org/10.1016/j.jacc.2007.01.087
  5. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819-24. https://doi.org/10.1056/NEJM198403293101304
  6. Vogel RA. Assessing stenosis significance by coronary arteriography: are the best variables good enough? J Am Coll Cardiol 1988;12:692-3. https://doi.org/10.1016/S0735-1097(88)80058-5
  7. Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J 2008;29:726-32. https://doi.org/10.1093/eurheartj/ehn045
  8. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME Study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-21. https://doi.org/10.1016/j.jacc.2009.11.096
  9. Yong AS, Ng AC, Brieger D, Lowe HC, Ng MK, Kritharides L. Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J 2011;32:345-53. https://doi.org/10.1093/eurheartj/ehq259
  10. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-8. https://doi.org/10.1056/NEJM199606273342604
  11. De Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans: feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation 1996;94:1842-9. https://doi.org/10.1161/01.CIR.94.8.1842
  12. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87:1354-67. https://doi.org/10.1161/01.CIR.87.4.1354
  13. De Bruyne B, Baudhuin T, Melin JA, et al. Coronary flow reserve calculated from pressure measurements in humans: validation with positron emission tomography. Circulation 1994;89:1013-22. https://doi.org/10.1161/01.CIR.89.3.1013
  14. Bech GJ, Droste H, Pijls NH, et al. Value of fractional flow reserve in making decisions about bypass surgery for equivocal left main coronary artery disease. Heart 2001;86:547-52. https://doi.org/10.1136/heart.86.5.547
  15. Lindstaedt M, Yazar A, Germing A, et al. Clinical outcome in patients with intermediate or equivocal left main coronary artery disease after deferral of surgical revascularization on the basis of fractional flow reserve measurements. Am Heart J 2006;152:156. e1-9. https://doi.org/10.1016/j.ahj.2006.03.026
  16. Potvin JM, Rodés-Cabau J, Bertrand OF, et al. Usefulness of fractional flow reserve measurements to defer revascularization in patients with stable or unstable angina pectoris, non-ST-elevation and ST-elevation acute myocardial infarction, or atypical chest pain. Am J Cardiol 2006; 98:289-97. https://doi.org/10.1016/j.amjcard.2006.02.032
  17. Fischer JJ, Wang XQ, Samady H, et al. Outcome of patients with acute coronary syndromes and moderate coronary lesions undergoing deferral of revascularization based on fractional flow reserve assessment. Catheter Cardiovasc Interv 2006;68:544-8.
  18. Berger A, Botman KJ, MacCarthy PA, et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 2005;46:438-42. https://doi.org/10.1016/j.jacc.2005.04.041
  19. Wongpraparut N, Yalamanchili V, Pasnoori V, et al. Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention. Am J Cardiol 2005;96:877-84. https://doi.org/10.1016/j.amjcard.2005.05.040
  20. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-75. https://doi.org/10.1161/CIRCULATIONAHA.105.557561
  21. Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study. J Am Coll Cardiol 2010;56:177-84. https://doi.org/10.1016/j.jacc.2010.04.012
  22. Fearon WF, Bornschein B, Tonino PA, et al. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010;122:2545-50. https://doi.org/10.1161/CIRCULATIONAHA.109.925396
  23. Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J Am Coll Cardiol 2011;58:1211-8. https://doi.org/10.1016/j.jacc.2011.06.020
  24. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010;31:2501-55. https://doi.org/10.1093/eurheartj/ehq277
  25. De Bruyne B, Pijls NH, Barbato E, et al. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 2003;107:1877-83. https://doi.org/10.1161/01.CIR.0000061950.24940.88
  26. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606. https://doi.org/10.1161/01.CIR.82.5.1595
  27. Kern MJ, Deligonul U, Tatineni S, Serota H, Aguirre F, Hilton TC. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease. J Am Coll Cardiol 1991;18:718-29. https://doi.org/10.1016/0735-1097(91)90795-B
  28. Lindstaedt M, Bojara W, Holland-Letz T, et al. Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access. Clin Res Cardiol 2009;98:717-23. https://doi.org/10.1007/s00392-009-0056-7
  29. Seo MK, Shin DH, Yang HM, et al. Comparison of hyperemic efficacy between central and peripheral veous adenosine infusion for fractional flow reserve measurement. Circulation 2010;122:A18620. Abstract.
  30. Nair PK, Marroquin OC, Mulukutla SR, et al. Clinical utility of regadenoson for assessing fractional flow reserve. JACC Cardiovasc Interv 2011;4:1085-92. https://doi.org/10.1016/j.jcin.2011.07.011
  31. Jang HJ, Koo BK, Kim JH, et al. Safety and efficacy of a novel hyperemic agent, nicorandil, for invasive physiologic assessment in a catheterization laboratory: a prospective multicenter study. Korean Circ J 2011;550608A. Abstract.
  32. Sen S, Escaned J, Malik IS, et al. Development and Validation of a New Adenosine-Independent Index of Stenosis Severity From Coronary Wave-Intensity Analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) Study. J Am Coll Cardiol 2012;59:1392-402. https://doi.org/10.1016/j.jacc.2011.11.003
  33. Kim HJ, Vignon-Clementel IE, Coogan JS, Figueroa CA, Jansen KE, Taylor CA. Patient-specific modeling of blood flow and pressure in human coronary arteries. Ann Biomed Eng 2010;38:3195-209. https://doi.org/10.1007/s10439-010-0083-6
  34. Koo BK, Erglis A, Doh JH, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninasive Fractional Flow Reserve) study. J Am Coll Cardiol 2011;58:1989-97. https://doi.org/10.1016/j.jacc.2011.06.066
  35. Min JK, Berman DS, Budoff MJ, et al. Rationale and design of the De-FACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) Study. J Cardiovasc Comput Tomogr 2011;5:301-9. https://doi.org/10.1016/j.jcct.2011.08.003

피인용 문헌

  1. Adenosine-stress low-dose single-scan CT myocardial perfusion imaging using a 128-slice dual-source CT: a comparison with fractional flow reserve vol.54, pp.4, 2012, https://doi.org/10.1177/0284185113475440
  2. Fractional flow reserve: Current applications and overview of the available data vol.3, pp.8, 2015, https://doi.org/10.12998/wjcc.v3.i8.678
  3. Usefulness of combined intravascular ultrasound parameters to predict functional significance of coronary artery stenosis and determinants of mismatch. vol.11, pp.2, 2012, https://doi.org/10.4244/eijv11i2a30
  4. Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting vol.15, pp.5, 2012, https://doi.org/10.4244/eij-d-18-00913